Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Restoring chemotherapy and hormone therapy sensitivity by parthenolide in a xenograft hormone refractory prostate cancer model.

Shanmugam R, Jayaprakasan V, Gokmen-Polar Y, Kelich S, Miller KD, Yip-Schneider M, Cheng L, Bhat-Nakshatri P, Sledge GW Jr, Nakshatri H, Zheng QH, Miller MA, DeGrado T, Hutchins GD, Sweeney CJ.

Prostate. 2006 Oct 1;66(14):1498-511.

PMID:
16921510
2.

Seroprevalence of bluetongue virus antibodies in sheep and goats in Kerala State, India.

Ravishankar C, Krishnan Nair G, Mini M, Jayaprakasan V.

Rev Sci Tech. 2005 Dec;24(3):953-8.

3.

Synthesis, conformational analysis, and biological activity of new analogues of thiazole-4-carboxamide adenine dinucleotide (TAD) as IMP dehydrogenase inhibitors.

Franchetti P, Cappellacci L, Pasqualini M, Petrelli R, Jayaprakasan V, Jayaram HN, Boyd DB, Jain MD, Grifantini M.

Bioorg Med Chem. 2005 Mar 15;13(6):2045-53.

PMID:
15727858
4.

Nuclear factor-kappaB is constitutively activated in prostate cancer in vitro and is overexpressed in prostatic intraepithelial neoplasia and adenocarcinoma of the prostate.

Sweeney C, Li L, Shanmugam R, Bhat-Nakshatri P, Jayaprakasan V, Baldridge LA, Gardner T, Smith M, Nakshatri H, Cheng L.

Clin Cancer Res. 2004 Aug 15;10(16):5501-7.

Supplemental Content

Loading ...
Support Center